Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
59%
OVERLAP
BY WEIGHT
16
# OF OVERLAPPING
HOLDINGS
OZEM
20
HOLDINGS
89%
ALSO IN THNR
THNR
20
HOLDINGS
80%
ALSO IN OZEM
SECTOR DRIFT (OZEM minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in OZEM |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.6% | 11.4% | 11.4% |
 |
NOVO-NORDISK A/S-SPONS ADR | 19.8% | 9.1% | 9.1% |
 |
ROCHE HOLDING LTD | 5.3% | 5.0% | 5.0% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 4.5% | 5.6% | 4.5% |
 |
INNOVENT BIOLOGICS, INC. | 4.4% | 5.2% | 4.4% |
OZEM Overweight Relative to THNR
|
NOVO-NORDISK A/S-SPONS ADR | 10.7% |
|
ELI LILLY & CO | 4.3% |
|
ZEALAND PHARMA A/S | 3.7% |
|
TERNS PHARMACEUTICALS, INC. | 2.8% |
|
SCHOLAR ROCK HOLDING CORP. | 2.5% |
 |
HANMI PHARM CO LTD | 2.2% |
|
VIKING THERAPEUTICS, INC. | 1.0% |
 |
THE UNITED LABORATORIES INTE | 0.8% |
|
ROCHE HOLDING LTD | 0.2% |
|
INNOVENT BIOLOGICS, INC. | -0.8% |
OZEM Underweight Relative to THNR
|
ABBVIE INC | -5.7% |
|
MERCK & CO. INC. | -5.5% |
|
REGENERON PHARMACEUTICALS | -5.3% |
|
GILEAD SCIENCES INC | -3.7% |
|
AMGEN INC | -3.6% |
|
HIMS & HERS HEALTH, INC. CLASS A | -3.3% |
|
CHINA PHARMACEUTICAL GROUP | -3.2% |
|
SHIONOGI & CO LTD | -3.1% |
 |
ASTRAZENECA PLC-SPONS ADR | -2.2% |
|
CRINETICS PHARMACEUTICALS INC | -1.7% |